EMI56 is a potent inhibitor of the EGFR triple mutant, demonstrating enhanced activity compared to its precursor, EMI1. This compound effectively targets and inhibits mutant forms of the epidermal growth factor receptor, making it valuable for research into EGFR-related pathologies, particularly in cancer models. EMI56 is suitable for studies focused on understanding resistance mechanisms and developing targeted therapeutic strategies.
EMI56 is a potent inhibitor of the EGFR triple mutant, demonstrating enhanced activity compared to its precursor, EMI1. This compound effectively targets and inhibits mutant forms of the epidermal growth factor receptor, making it valuable for research into EGFR-related pathologies, particularly in cancer models. EMI56 is suitable for studies focused on understanding resistance mechanisms and developing targeted therapeutic strategies.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
